{"id":57152,"date":"2023-07-02T10:23:30","date_gmt":"2023-07-02T10:23:30","guid":{"rendered":"https:\/\/finalreview.in\/index.php\/2023\/07\/02\/xoma-corp-8-625-pfd-series-a-xomap-biotechnology-united-states\/"},"modified":"2023-07-02T10:38:50","modified_gmt":"2023-07-02T10:38:50","slug":"xoma-corp-8-625-pfd-series-a-xomap-biotechnology-united-states","status":"publish","type":"post","link":"https:\/\/finalreview.in\/index.php\/2023\/07\/02\/xoma-corp-8-625-pfd-series-a-xomap-biotechnology-united-states\/","title":{"rendered":"XOMA Corp. 8.625% Pfd. Series A (XOMAP) &#8211; Biotechnology &#8211; United States"},"content":{"rendered":"","protected":false},"excerpt":{"rendered":"","protected":false},"author":2269,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"om_disable_all_campaigns":false,"_uag_custom_page_level_css":"","_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"_uf_show_specific_survey":0,"_uf_disable_surveys":false,"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[1,305],"tags":[304],"class_list":["post-57152","post","type-post","status-publish","format-standard","hentry","category-hospitality","category-united-states","tag-united-states"],"jetpack_featured_media_url":"","uagb_featured_image_src":{"full":false,"thumbnail":false,"medium":false,"medium_large":false,"large":false,"1536x1536":false,"2048x2048":false,"trp-custom-language-flag":false,"arpw-thumbnail":false,"mailpoet_newsletter_max":false,"woocommerce_thumbnail":false,"woocommerce_single":false,"woocommerce_gallery_thumbnail":false},"uagb_author_info":{"display_name":"Dr Surojit On duty medical officer","author_link":"https:\/\/finalreview.in\/index.php\/author\/dr-surojit-on-duty-medical-officer\/"},"uagb_comment_info":6,"uagb_excerpt":null,"jetpack-related-posts":[{"id":57153,"url":"https:\/\/finalreview.in\/index.php\/2023\/07\/02\/xoma-corp-dep-pfd-rep-8-375-cum-pfd-series-b-xomao-biotechnology-united-states\/","url_meta":{"origin":57152,"position":0},"title":"XOMA Corp. Dep. Pfd. (Rep. 8.375% Cum. Pfd. Series B) (XOMAO) &#8211; Biotechnology &#8211; United States","author":"Dr Surojit On duty medical officer","date":"July 2, 2023","format":false,"excerpt":"","rel":"","context":"In &quot;Hospitality&quot;","block_context":{"text":"Hospitality","link":"https:\/\/finalreview.in\/index.php\/category\/hospitality\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":57151,"url":"https:\/\/finalreview.in\/index.php\/2023\/07\/02\/xoma-corp-xoma-biotechnology-united-states\/","url_meta":{"origin":57152,"position":1},"title":"XOMA Corp. (XOMA) &#8211; Biotechnology &#8211; United States","author":"Dr Surojit On duty medical officer","date":"July 2, 2023","format":false,"excerpt":"","rel":"","context":"In &quot;Hospitality&quot;","block_context":{"text":"Hospitality","link":"https:\/\/finalreview.in\/index.php\/category\/hospitality\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":51281,"url":"https:\/\/finalreview.in\/index.php\/2023\/07\/02\/fortress-biotech-inc-9-375-cum-pfd-series-a-biotechnology-united-states\/","url_meta":{"origin":57152,"position":2},"title":"Fortress Biotech Inc. 9.375% Cum. Pfd. Series A &#8211; Biotechnology &#8211; United States","author":"Admin","date":"July 2, 2023","format":false,"excerpt":"","rel":"","context":"In &quot;Hospitality&quot;","block_context":{"text":"Hospitality","link":"https:\/\/finalreview.in\/index.php\/category\/hospitality\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":54962,"url":"https:\/\/finalreview.in\/index.php\/2023\/07\/02\/regen-biopharma-inc-non-cum-pfd-series-a-rgbpp-biotechnology-united-states\/","url_meta":{"origin":57152,"position":3},"title":"Regen BioPharma Inc. Non-Cum. Pfd. Series A (RGBPP) &#8211; Biotechnology &#8211; United States","author":"Admin","date":"July 2, 2023","format":false,"excerpt":"","rel":"","context":"In &quot;Hospitality&quot;","block_context":{"text":"Hospitality","link":"https:\/\/finalreview.in\/index.php\/category\/hospitality\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":56491,"url":"https:\/\/finalreview.in\/index.php\/2023\/07\/02\/two-harbors-investment-corp-8-125-cum-redeem-pfd-series-a-two-pra-mortgage-reits-united-states\/","url_meta":{"origin":57152,"position":4},"title":"Two Harbors Investment Corp. 8.125% Cum. Redeem. Pfd. Series A (TWO.PRA) &#8211; Mortgage REITs &#8211; United States","author":"Dr Surojit On duty medical officer","date":"July 2, 2023","format":false,"excerpt":"","rel":"","context":"In &quot;Hospitality&quot;","block_context":{"text":"Hospitality","link":"https:\/\/finalreview.in\/index.php\/category\/hospitality\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":51228,"url":"https:\/\/finalreview.in\/index.php\/2023\/07\/02\/fluor-corp-perp-pfd-conv-series-a-144a-construction-united-states\/","url_meta":{"origin":57152,"position":5},"title":"Fluor Corp. Perp. Pfd. Conv. Series A 144A &#8211; Construction &#8211; United States","author":"Admin","date":"July 2, 2023","format":false,"excerpt":"","rel":"","context":"In &quot;Hospitality&quot;","block_context":{"text":"Hospitality","link":"https:\/\/finalreview.in\/index.php\/category\/hospitality\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]}],"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/finalreview.in\/index.php\/wp-json\/wp\/v2\/posts\/57152","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/finalreview.in\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/finalreview.in\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/finalreview.in\/index.php\/wp-json\/wp\/v2\/users\/2269"}],"replies":[{"embeddable":true,"href":"https:\/\/finalreview.in\/index.php\/wp-json\/wp\/v2\/comments?post=57152"}],"version-history":[{"count":1,"href":"https:\/\/finalreview.in\/index.php\/wp-json\/wp\/v2\/posts\/57152\/revisions"}],"predecessor-version":[{"id":57252,"href":"https:\/\/finalreview.in\/index.php\/wp-json\/wp\/v2\/posts\/57152\/revisions\/57252"}],"wp:attachment":[{"href":"https:\/\/finalreview.in\/index.php\/wp-json\/wp\/v2\/media?parent=57152"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/finalreview.in\/index.php\/wp-json\/wp\/v2\/categories?post=57152"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/finalreview.in\/index.php\/wp-json\/wp\/v2\/tags?post=57152"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}